BRM270 targets cancer stem cells and augments chemo-sensitivity in cancer. - Chandimali, Nisansala; Koh, Hyebin; Kim, Jihwan; Lee, Jaihyung; Park, Yang Ho; Sun, Hu-Nan; Kwon, Taeho (Oncology Letters, 2020)